Gelteq (NASDAQ:GELS – Get Free Report) posted its quarterly earnings results on Monday. The company reported ($0.64) EPS for the quarter, FiscalAI reports.
Gelteq Trading Up 0.7%
NASDAQ:GELS traded up $0.00 during mid-day trading on Wednesday, hitting $0.27. The company had a trading volume of 8,224 shares, compared to its average volume of 2,145,412. The business has a fifty day simple moving average of $0.51 and a 200-day simple moving average of $0.63. Gelteq has a 1 year low of $0.26 and a 1 year high of $2.01.
Wall Street Analysts Forecast Growth
Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of Gelteq in a research note on Tuesday, September 22nd. One equities research analyst has rated the stock with a Sell rating. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Sell”.
Get Our Latest Stock Analysis on Gelteq
About Gelteq
Gelteq is an Australian food-technology company that develops gel-based delivery systems for ingredients used in human and animal health products. Its platform is designed to incorporate active ingredients into gels as an alternative format to conventional tablets, capsules, powders and liquids. The company’s applications include nutraceuticals and dietary supplements, pharmaceutical products, and animal-health and nutrition products. Gelteq works with businesses seeking to develop or manufacture products using its gel technology.
Read More
- Five stocks we like better than Gelteq
- SpaceX’s Historic Starship Catch Raises a Bigger Question About Its AI Spending
- AMD Bets $8.2B on Physical AI: Could Robotics Be Its Next Growth Frontier?
- 3 Stocks Flashing Buy Signals With Historical Win Rates Above 85% After the Sell-Off
- Disney Has the Magic Touch: Dividend Growth and Buybacks Could Fuel a Breakout
Receive News & Ratings for Gelteq Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gelteq and related companies with MarketBeat.com's FREE daily email newsletter.
